Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT.
Pagliuca S, Schmid C, Santoro N, Simonetta F, Battipaglia G, Guillaume T, Greco R, Onida F, Sánchez-Ortega I, Yakoub-Agha I, Kuball J, Hazenberg MD, Ruggeri A; Practice Harmonization and Guidelines Committee and the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Lancet Haematol. 2024 Jun;11(6):e448-e458. doi: 10.1016/S2352-3026(24)00098-X.
Modification of donor lymphocyte infusion: how to improve the outcome?
Wang Y, Xu L, Yan C, Huang X.
Sci China Life Sci. 2019 Sep;62(9):1253-1256. doi: 10.1007/s11427-019-9597-3. Epub 2019 Jul 30.
Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation.
Roddie C, Peggs KS.
Expert Opin Biol Ther. 2011 Apr;11(4):473-87. doi: 10.1517/14712598.2011.554811. Epub 2011 Jan 27.
Changes in donor lymphocyte infusion for relapsed patients post-hematopoietic stem cell transplantation: a 30-year single-center experience.
Uchibori Y, Kurosawa S, Najima Y, Haraguchi K, Sadato D, Hirama C, Sadaga Y, Kondo K, Kato C, Sakai S, Kambara Y, Ouchi F, Shimabukuro M, Jinguji A, Shingai N, Toya T, Shimizu H, Kobayashi T, Harada H, Harada Y, Okuyama Y, Doki N.
Front Immunol. 2025 Jan 29;16:1521895. doi: 10.3389/fimmu.2025.1521895. eCollection 2025.
Strategies for improving the efficacy of donor lymphocyte infusion following stem cell transplantation.
Stamouli M, Gkirkas K, Tsirigotis P.
Immunotherapy. 2016;8(1):57-68. doi: 10.2217/imt.15.100. Epub 2015 Dec 7.
Concomitant use of blinatumomab and donor lymphocyte infusion for mixed-phenotype acute leukemia: a case report with literature review.
Durer S, Durer C, Shafqat M, Comba IY, Malik S, Faridi W, Aslam S, Ijaz A, Tariq MJ, Fraz MA, Usman M, Khan AY, McBride A, Anwer F.
Immunotherapy. 2019 Apr;11(5):373-378. doi: 10.2217/imt-2018-0104.
Donor Lymphocyte Infusion in Hematologic Malignancies--Good to be Fresh?
Hossain NM, Klumpp T, Ulicny J, Garner M, Kropf PL, Mangan KF, Barta SK, Fung HC, Martin ME.
Clin Lymphoma Myeloma Leuk. 2016 Feb;16(2):111-5. doi: 10.1016/j.clml.2015.10.004. Epub 2015 Nov 3.
Donor lymphocyte infusions.
Dazzi F, Goldman J.
Curr Opin Hematol. 1999 Nov;6(6):394-9. doi: 10.1097/00062752-199911000-00007.
Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant.
Bednarski JJ, Zimmerman C, Berrien-Elliott MM, Foltz JA, Becker-Hapak M, Neal CC, Foster M, Schappe T, McClain E, Pence PP, Desai S, Kersting-Schadek S, Wong P, Russler-Germain DA, Fisk B, Lie WR, Eisele J, Hyde S, Bhatt ST, Griffith OL, Griffith M, Petti AA, Cashen AF, Fehniger TA.
Blood. 2022 Mar 17;139(11):1670-1683. doi: 10.1182/blood.2021013972.
Donor-derived regulatory dendritic cell infusion modulates effector CD8(+) T cell and NK cell responses after liver transplantation.
Tran LM, Macedo C, Zahorchak AF, Gu X, Elinoff B, Singhi AD, Isett B, Zeevi A, Sykes M, Breen K, Srivastava A, Ables EM, Landsittel D, Styn MA, Humar A, Lakkis FG, Metes DM, Thomson AW.
Sci Transl Med. 2023 Oct 11;15(717):eadf4287. doi: 10.1126/scitranslmed.adf4287. Epub 2023 Oct 11.
